Correlation Between Cidara Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cidara Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cidara Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cidara Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on Cidara Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cidara Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cidara Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for Cidara Therapeutics and X4 Pharmaceuticals
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cidara and XFOR is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Cidara Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Cidara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cidara Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Cidara Therapeutics i.e., Cidara Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cidara Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days Cidara Therapeutics is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cidara Therapeutics is 2.89 times less risky than X4 Pharmaceuticals. The stock trades about -0.13 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 64.00 in X4 Pharmaceuticals on November 9, 2024 and sell it today you would lose (9.00) from holding X4 Pharmaceuticals or give up 14.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cidara Therapeutics vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Cidara Therapeutics |
| X4 Pharmaceuticals |
Cidara Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cidara Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite Cidara Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cidara Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |